About this trial
The aim of this study is to investigate if personalized dosing of antidepressant medications using information gathered at the Personalized Medicine Clinic can improve patients' mental health. The main question it aims to answer is if the Personalized Medicine Clinic can improve depressive symptoms based on the CES-D survey score.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Depressive symptoms
Disqualifiers
Patients who do not speak English
Patients with severe mental illness including hospitalized patients or patients with suicidal ideation
Trial population
Adult patients referred to the Personalized Medicine clinic for genotype-guided drug dosing and selection related to mental health pharmacotherapy as part of clinical care.
Trial design
Cohort
Prospective
Treatments tested in this trial
Personalized Medicine Clinic
Other interventionPersonalized Medicine Clinic services with specific focus on pharmacogenetic recommendations and patient education.
Treatment groups
Trial outcomes
Primary outcomes
CES-D Survey Score
CES-D survey score is a 20-item self-reported questionnaire that was designed to assess depressive symptoms. The score is from 0-60 with higher numbers indicating greater depressive symptoms.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: